ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

Funding Opportunities (8-page issue).

April 25, 2003

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

FDA Approves Implant For Breast Reconstruction

July 26, 2013